As the team behind the AI-native agentic platform for digital validation, we’re thrilled to join senior manufacturing leaders, engineers, and decision-makers at one of biopharma’s most focused scale-up forums.
PharmaXcelerate USA 2026 brings together the industry’s leading voices — from AstraZeneca and Pfizer to Biogen and Eli Lilly — to tackle the real challenges of scaling complex therapies into commercial reality. With sessions covering Annex 1 compliance, digital twins, AI-driven manufacturing, and tech transfer, this is exactly where the conversation around the future of regulated production is happening.
If you’re attending and want to explore how continuous, AI-driven validation can help your organization move faster and stay compliant at scale — come find us. We’d love to connect.
See you in Philadelphia. PharmaXcelerate | biopharma manufacturing | scale-up
